LeMaitre Vascular Ownership

LMAT Stock  USD 83.49  2.19  2.56%   
LeMaitre Vascular maintains a total of 22.56 Million outstanding shares. The majority of LeMaitre Vascular outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in LeMaitre Vascular to benefit from reduced commissions. Accordingly, institutional holders are subject to a different set of regulations than regular investors in LeMaitre Vascular. Please pay attention to any change in the institutional holdings of LeMaitre Vascular as this could imply that something significant has changed or is about to change at the company. Also note that almost nine hundred ninety-nine thousand three hundred fourty-six invesors are currently shorting LeMaitre Vascular expressing very little confidence in its future performance.
 
Shares in Circulation  
First Issued
2004-03-31
Previous Quarter
22.8 M
Current Value
22.9 M
Avarage Shares Outstanding
17.1 M
Quarterly Volatility
4.4 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, LeMaitre Vascular's Dividends Paid is comparatively stable compared to the past year. Dividend Yield is likely to gain to 0.01 in 2025, whereas Dividend Paid And Capex Coverage Ratio is likely to drop 1.24 in 2025. Net Income Applicable To Common Shares is likely to gain to about 24.9 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 17.6 M in 2025.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LeMaitre Vascular. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy LeMaitre Stock please use our How to Invest in LeMaitre Vascular guide.

LeMaitre Stock Ownership Analysis

About 96.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.23. LeMaitre Vascular last dividend was issued on the 13th of March 2025. LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. Lemaitre Vascular operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 450 people. To find out more about LeMaitre Vascular contact George LeMaitre at 781 221 2266 or learn more at https://www.lemaitre.com.
Besides selling stocks to institutional investors, LeMaitre Vascular also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different LeMaitre Vascular's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align LeMaitre Vascular's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

LeMaitre Vascular Quarterly Liabilities And Stockholders Equity

551.82 Million

LeMaitre Vascular Insider Trades History

About 9.0% of LeMaitre Vascular are currently held by insiders. Unlike LeMaitre Vascular's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against LeMaitre Vascular's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of LeMaitre Vascular's insider trades
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

LeMaitre Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as LeMaitre Vascular is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading LeMaitre Vascular backward and forwards among themselves. LeMaitre Vascular's institutional investor refers to the entity that pools money to purchase LeMaitre Vascular's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Northern Trust Corp2024-12-31
327.8 K
T. Rowe Price Associates, Inc.2024-12-31
284.8 K
Driehaus Capital Management Llc2024-12-31
263.2 K
Envestnet Asset Management Inc2024-12-31
259.4 K
Acadian Asset Management Llc2024-12-31
236.8 K
Rice Hall James & Associates, Llc2024-12-31
235.1 K
Goldman Sachs Group Inc2024-12-31
206.6 K
Charles Schwab Investment Management Inc2024-12-31
195.8 K
Kayne Anderson Rudnick Investment Management Llc2024-12-31
193.1 K
Blackrock Inc2024-12-31
3.9 M
Conestoga Capital Advisors, Llc2024-12-31
1.7 M
Note, although LeMaitre Vascular's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

LeMaitre Vascular Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific LeMaitre Vascular insiders, such as employees or executives, is commonly permitted as long as it does not rely on LeMaitre Vascular's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases LeMaitre Vascular insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

LeMaitre Vascular Outstanding Bonds

LeMaitre Vascular issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. LeMaitre Vascular uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most LeMaitre bonds can be classified according to their maturity, which is the date when LeMaitre Vascular has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

LeMaitre Vascular Corporate Filings

F3
21st of March 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
F4
14th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10K
28th of February 2025
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
8K
27th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for LeMaitre Stock Analysis

When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.